doxorubicin (Qrono)

N/A

Report date: 2025/12/12 17:31:45

Base Information

Drug Namedoxorubicin (Qrono)
Drug Alias NamedoxorubicinQR-212
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Anthracycline antibiotics
Mechanisms of ActionTopoisomerase II inhibitorsVirus DNA polymerase inhibitorsDNA intercalators
TargetsTopoisomerase IIDNAVirus DNA polymerase
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesQrono Inc
China Registration ClassN/A

Develop Information

Active CompaniesQrono Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A